Comparison of Ultrasound-Guided Infraclavicular Block and Ultrasound-Guided Axillary Block

NCT ID: NCT01761175

Last Updated: 2017-08-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

224 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the rate of complete sensory block at 30 minutes following ultrasound-guided single injection infraclavicular block and ultrasound-guided double injection axillary block. The investigators research hypothesis is that both blocks will show comparable rates of complete sensory block at 30 minutes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ultrasound-guided infraclavicular block

Ultrasound-guided single injection infraclavicular block

Group Type ACTIVE_COMPARATOR

Ultrasound-guided infraclavicular block

Intervention Type PROCEDURE

Ultrasound-guided single injection infraclavicular block: using an in-plane technique, 30 mL of mepivacaine 1.5% is injected at the posterior aspect of the artery.

Ultrasound-guided axillary block

Ultrasound-guided double injection axillary block

Group Type ACTIVE_COMPARATOR

Ultrasound-guided axillary block

Intervention Type PROCEDURE

Ultrasound-guided double injection axillary block: using an in-plane technique, 25 mL of mepivacaine 1.5% is injected postero-medial to the artery. During needle withdrawal, 5 mL of the same solution is injected close to the musculocutaneous nerve.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound-guided infraclavicular block

Ultrasound-guided single injection infraclavicular block: using an in-plane technique, 30 mL of mepivacaine 1.5% is injected at the posterior aspect of the artery.

Intervention Type PROCEDURE

Ultrasound-guided axillary block

Ultrasound-guided double injection axillary block: using an in-plane technique, 25 mL of mepivacaine 1.5% is injected postero-medial to the artery. During needle withdrawal, 5 mL of the same solution is injected close to the musculocutaneous nerve.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* American Society of Anesthesiologists Class 1 to 3
* Undergoing a surgery at the elbow, forearm, wrist or hand under regional anesthesia

Exclusion Criteria

* Age less than 18 years
* Body mass index more than 40 kg/m2
* Weight less than 45 kg
* Patient refusal
* Contraindication to regional anesthesia (coagulopathy, local infection at the puncture site, systemic infection)
* Previous neurological deficit in the operated arm
* Severe renal or hepatic failure
* Prior surgery in the axillary or infraclavicular area
* Pregnancy or breast-feeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CHU de Quebec-Universite Laval

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ariane Boivin

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ariane Boivin, MD

Role: PRINCIPAL_INVESTIGATOR

CHU de Québec

Marie-Josée Nadeau, MD

Role: PRINCIPAL_INVESTIGATOR

CHU de Québec

Nicolas Dion, MD

Role: PRINCIPAL_INVESTIGATOR

CHU de Québec

Simon Lévesque, MD

Role: PRINCIPAL_INVESTIGATOR

CHU de Québec

Pierre C. Nicole, MD

Role: PRINCIPAL_INVESTIGATOR

CHU de Québec

Alexis F. Turgeon, MD, Msc

Role: PRINCIPAL_INVESTIGATOR

CHU de Québec

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital de l'Enfant-Jésus

Québec, , Canada

Site Status

Hôpital de Saint-Sacrement

Québec, , Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Boivin A, Nadeau MJ, Dion N, Levesque S, Nicole PC, Turgeon AF. Ultrasound-Guided Single-Injection Infraclavicular Block Versus Ultrasound-Guided Double-Injection Axillary Block: A Noninferiority Randomized Controlled Trial. Anesth Analg. 2016 Jan;122(1):273-8. doi: 10.1213/ANE.0000000000001017.

Reference Type DERIVED
PMID: 26516803 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEJ-666

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.